FIELD: medicine.
SUBSTANCE: saccharide chain-polypeptide complexes are characterized in that the polypeptide is a polypeptide comprising an amino acid sequence which is composed of 8 to 34 amino acid residues, in which polar and non-polar amino acid residues are arranged alternately, and one or more saccharide chains are bound to the polypeptide and the total number of saccharide residues present in the one or more saccharide chains bound to said polypeptide is 5 or more.
EFFECT: invention relates to saccharide chain-polypeptide complexes that can form a transparent and homogeneous hydrogel over a wide pH range.
15 cl, 7 dwg, 6 tbl, 10 ex
Title | Year | Author | Number |
---|---|---|---|
GLYCOSYLATED POLYPEPTIDES AND MEDICINAL COMPOSITIONS CONTAINING THESE POLYPEPTIDES | 2012 |
|
RU2627184C2 |
GLYCOSYLATED POLYPEPTIDES AND MEDICINAL COMPOSITIONS CONTAINING THESE POLYPEPTIDES | 2012 |
|
RU2624034C2 |
GLP-1 PEPTIDE HAVING ATTACHED OLIGOSACCHARIDE CHAIN | 2008 |
|
RU2539829C2 |
METHOD OF PRODUCING GLYCOPROTEIN AND SCREENING METHOD | 2009 |
|
RU2520240C2 |
METHOD OF PRODUCING PEPTIDE | 2008 |
|
RU2478105C2 |
GLYCOSYLATED POLYPEPTIDE AND ITS PHARMACEUTICAL COMPOSITION | 2012 |
|
RU2636456C2 |
POLYPEPTIDE GLYCOSYLATED WITH SIALYLATED SUGAR CHAIN | 2014 |
|
RU2668163C2 |
BISPECIFIC ANTI-HAPTEN/ANTI-BLOOD BRAIN BARRIER RECEPTOR ANTIBODIES, COMPLEXES THEREOF AND THEIR USE AS BLOOD BRAIN BARRIER SHUTTLES | 2014 |
|
RU2693438C2 |
GLYCATED PEPTIDE GLP-1 | 2009 |
|
RU2543157C2 |
PROCESS FOR PREPARATION OF GLYCOPEPTIDE HAVING SIALYLATED SUGAR CHAIN, AND METHOD FOR PRODUCING SIALYL GLYCOASPARAGINE | 2012 |
|
RU2586524C2 |
Authors
Dates
2018-08-20—Published
2014-03-21—Filed